Lipo Trim Description:NOW Lipo Trim is a combination of nutrients that support fat digestion, metabolism, and utilization. Choline and Inositol aid in the metabolism of fat by the liver. The amino acid Taurine has been included to support bile production, which is essential for the digestion and absorption of dietary fats. Carnitine is critical in all tissues for the transport of fatty acids into the mitochondria, where the cells' energy is produced. This synergistic blend of ingredients therefore supports many aspects of healthy fat metabolism, which, in turn, may promote higher energy levels.
Lipo Trim Ingredients:
Other Ingredients: Calcium Carbonate, Cellulose, Stearic Acid (vegetable source), Silica, Croscarmellose Sodium and Magnesium Stearate (vegetable source).
Lipo Trim Notes:
Free of sugar, salt, starch, yeast, wheat, gluten, soy, milk, egg or preservatives.
Size: 120 Tabs
Retail Price: $19.99
Our Price: $15.99
Click Now ---- > Buy Now
Statements contained herein have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat and cure or prevent disease. Always consult with your professional health care provider before changing any medication.
Statements contained herein have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat and cure or prevent disease. Always consult with your professional health care provider before changing any medication.
Lipo Trim Article:
Howard Foundation Research Ltd (HFR) was established in 1985 with Dr Stephen Kreitzman Ph.D, R. Nutr. as senior scientist and managing director. HFR promotes research into obesity, organises training for medical practitioners and administers the Lipotrim Obesity Management Programme for general practice, hospitals and pharmacies.
Treatment for obese patients:
In 1987, as a result of the successful loss of substantial weight by obese study subjects, a programme was developed for GPs to treat their obese patients using the protocols developed during the research. Very high compliance and weight losses, generally at theoretical maximal levels, were achieved in the research and the subsequent Lipotrim programme.
Lipotrim is not available to the general public over the counter. The GP retains complete control over the patient’s use of the programme. Over the years, Lipotrim’s value in Type II diabetes control, blood pressure reduction and a host of other clinical benefits. has sustained its medical use.
Lipotrim is not available to the general public over the counter. The GP retains complete control over the patient’s use of the programme. Over the years, Lipotrim’s value in Type II diabetes control, blood pressure reduction and a host of other clinical benefits. has sustained its medical use.
Training for Pharmacists:
With the growing burdens on resources of general practice and the increasing recognition of the epidemic of obesity, several groups of GPs were consulted in "think tank" sessions to develop ideas for the wider availability of the Lipotrim programme. The universal conclusion was that expansion into pharmacy was the best possible scenario. As highly educated members of the medical team, pharmacists are well placed to treat uncomplicated weight problems, maintaining the professionalism required when managing seriously overweight people. Therefore, in 2001, the Lipotrim programmes were extended to include training for pharmacists. This training programme earned a "Highly Commended" in the 2002 SMART awards sponsored by Numark and Pharmacy Magazine. Over 20 Royal Pharmaceutical Society branch educational sessions on obesity management have been conducted to-date by Howard Foundation Research’s scientists, Dr Stephen Kreitzman and Valerie Beeson.
Training in the use of the programme in general practice or pharmacy is provided free of charge. All materials needed by patients and staff are provided without cost.
Dr Stephen Kreitzman Ph.D, R. Nutr. is a nutritional biochemist. After training at the Massachusetts Institute of Technology (MIT) in the United States, he taught nutrition to medical students in the US, researched obesity, body composition and metabolism in both the US and UK. He has been senior research associate at Cambridge University in the UK and is a UK registered nutritionist.
Dr Kreitzman’s work has been published in, among others, the Lancet, the International Journal of Obesity, the American Journal of Clinical Nutrition, the European Journal of Applied Physiology and the Royal College of General Practitioners Members’ Reference Book.
Valerie Beeson is a research scientist, widely published in the field of obesity and metabolism. She is an experienced medical educator and trainer, participating in numerous PGEA programmes on obesity management. As clinical programme director for Lipotrim, she is the primary liaison for practice staff and pharmacists and involved in the organisation of new programmes and ongoing support of all existing programmes.
Lipotrim Diet in General Practice:
Sir,
I was interested to read Dr Molokhia ‘s experiences with the Lipo Trim diet (May Journal). 1 the same diet was introduced into our practice in 1994. initial enthusiasm with impressive weight loss in some of the most obese patients was later tempered by caution following gradual return of weight over the following two years. All patients were offered full dietary advice on returning for the refeeding programmme. Because of the amount of doctor and nurse time taken up with implementing the diet, after 1996. new patients were only taken on in exceptional circumstances.
At the first audit in 1996, 42 patients who had stayed on the diet for at least on month were weighed. The average body mass index (BMI) reduction was 5.02. Average weight loss totalled 14 kgs. This compares with Dr Molokhia’s results of 6.1 and 15 kg respectively after 12 months. Twenty-one (50%) of our patients had returned for the refeeding programme. Sixty per cent of these had put back on less than 6 kg in weight. The second follow-up has just been completed. A computer search identified patients who had started on the Lipotrim diet in 1994–1995, and invitations were sent for re-weighing and further diet advice from the practice nurse. The total number of patients starting the diet was 72, of which 58 (80.5%) completed the diet and 39 attended follow-up. The weights of these 39 patients were compared with their weight before starting the Lipotrim diet. Sixteen of the 39 patients had a similar weight from when they started, three had gained more than 6 kg, seven had lost 6 to 12 kg, and 13 had lost more than 12 kg. It seems likely that the 19 patients who did not attend for follow-up did not sustain
any significant weight loss. Given this bias, an average weight loss or BMI reduction in the attenders would be misleading Overall, 13 of the 58 patients completing the diet (25%) maintained a very significant weight loss. One patient was able to have a successful knee replacement after his BMI came down from 42 to 34. Very low calorie diets such as Lipotrim can be useful for well-selected patients. They require a high degree of commitment and motivation from the patients and time-consuming support from nurses and GPs.
JEAN BROWN
Coleridge Medical Centre
Ottery St Mary
Devon EX11 1EQ
Reference
1. Molokhia M. Obesity wars: a pilot study of very low calorie diets in obese patients in general practice. Br J Gen Pract 1998; 48:
1251-1252.
Sir,
I was interested to read Dr Molokhia ‘s experiences with the Lipo Trim diet (May Journal). 1 the same diet was introduced into our practice in 1994. initial enthusiasm with impressive weight loss in some of the most obese patients was later tempered by caution following gradual return of weight over the following two years. All patients were offered full dietary advice on returning for the refeeding programmme. Because of the amount of doctor and nurse time taken up with implementing the diet, after 1996. new patients were only taken on in exceptional circumstances.
At the first audit in 1996, 42 patients who had stayed on the diet for at least on month were weighed. The average body mass index (BMI) reduction was 5.02. Average weight loss totalled 14 kgs. This compares with Dr Molokhia’s results of 6.1 and 15 kg respectively after 12 months. Twenty-one (50%) of our patients had returned for the refeeding programme. Sixty per cent of these had put back on less than 6 kg in weight. The second follow-up has just been completed. A computer search identified patients who had started on the Lipotrim diet in 1994–1995, and invitations were sent for re-weighing and further diet advice from the practice nurse. The total number of patients starting the diet was 72, of which 58 (80.5%) completed the diet and 39 attended follow-up. The weights of these 39 patients were compared with their weight before starting the Lipotrim diet. Sixteen of the 39 patients had a similar weight from when they started, three had gained more than 6 kg, seven had lost 6 to 12 kg, and 13 had lost more than 12 kg. It seems likely that the 19 patients who did not attend for follow-up did not sustain
any significant weight loss. Given this bias, an average weight loss or BMI reduction in the attenders would be misleading Overall, 13 of the 58 patients completing the diet (25%) maintained a very significant weight loss. One patient was able to have a successful knee replacement after his BMI came down from 42 to 34. Very low calorie diets such as Lipotrim can be useful for well-selected patients. They require a high degree of commitment and motivation from the patients and time-consuming support from nurses and GPs.
JEAN BROWN
Coleridge Medical Centre
Ottery St Mary
Devon EX11 1EQ
Reference
1. Molokhia M. Obesity wars: a pilot study of very low calorie diets in obese patients in general practice. Br J Gen Pract 1998; 48:
1251-1252.
Title: Buy Lipo Trim By Now
Blog's URL: http://lipo-trim.blogspot.com/
Description: NOW Lipo Trim is a combination of nutrients that support fat digestion, metabolism, and utilization. Choline and Inositol aid in the metabolism of fat by the liver
No comments:
Post a Comment